Defining the subset of the patients in whom "Less is More" for hormone receptor-positive breast cancer: Clinical risk vs. genomics risk

Yeon Hee Park

doi:10.21037/tcr.2017.02.19

Defining the subset of the patients in whom "Less is More" for hormone receptor-positive breast cancer: Clinical risk vs. genomics risk

Yeon Hee Park

Department of Internal Medicine

Research output: Contribution to journal › Comment/debate

Original language	English
Pages (from-to)	S42-S43
Journal	Translational Cancer Research
Volume	6
DOIs	https://doi.org/10.21037/tcr.2017.02.19
State	Published - 2017

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.21037/tcr.2017.02.19

Cite this

@article{9f2a83294ead4ce587e5c170cd1062bb,

title = "Defining the subset of the patients in whom {"}Less is More{"} for hormone receptor-positive breast cancer: Clinical risk vs. genomics risk",

author = "Park, \{Yeon Hee\}",

year = "2017",

doi = "10.21037/tcr.2017.02.19",

language = "English",

volume = "6",

pages = "S42--S43",

journal = "Translational Cancer Research",

issn = "2218-676X",

publisher = "AME Publishing Company",

}

TY - JOUR

T1 - Defining the subset of the patients in whom "Less is More" for hormone receptor-positive breast cancer

T2 - Clinical risk vs. genomics risk

AU - Park, Yeon Hee

PY - 2017

Y1 - 2017

UR - https://www.scopus.com/pages/publications/85014106855

U2 - 10.21037/tcr.2017.02.19

DO - 10.21037/tcr.2017.02.19

M3 - Comment/debate

AN - SCOPUS:85014106855

SN - 2218-676X

VL - 6

SP - S42-S43

JO - Translational Cancer Research

JF - Translational Cancer Research

ER -

Defining the subset of the patients in whom "Less is More" for hormone receptor-positive breast cancer: Clinical risk vs. genomics risk

UN SDGs

Access to Document

Other files and links

Cite this